Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7WMF

Threonyl-tRNA synthetase from Salmonella enterica in complex with an inhibitor

Summary for 7WMF
Entry DOI10.2210/pdb7wmf/pdb
DescriptorThreonine--tRNA ligase, (2S,3R)-2-azanyl-N-[(1R)-2-[3-[6,7-bis(chloranyl)-4-oxidanylidene-quinazolin-3-yl]propanoylamino]-1-[3-[4-(trifluoromethyl)phenyl]phenyl]ethyl]-3-oxidanyl-butanamide, 1,2-ETHANEDIOL, ... (5 entities in total)
Functional Keywordsligase-inhibitor complex, ligase/inhibitor
Biological sourceSalmonella enterica subsp. enterica serovar Cubana str. 76814
Total number of polymer chains2
Total formula weight97422.86
Authors
Cai, Z.,Chen, B.,Yu, Y.,Zhou, H. (deposition date: 2022-01-14, release date: 2022-04-27, Last modification date: 2023-11-29)
Primary citationCai, Z.,Chen, B.,Yu, Y.,Guo, J.,Luo, Z.,Cheng, B.,Xu, J.,Gu, Q.,Zhou, H.
Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases.
J.Med.Chem., 65:5800-5820, 2022
Cited by
PubMed Abstract: Aminoacyl-tRNA synthetases (aaRSs) are promising drug targets due to their essential roles in protein translation. Although current inhibitors primarily occupy one or two of the three substrate binding sites on aaRSs, we report here the structure-based design of the first class of triple-site aaRS inhibitors by targeting threonyl-tRNA synthetase (ThrRS). Competition of our compounds with all three substrates on ThrRS binding was confirmed isothermal titration calorimetry assays. Cocrystal structures of three compounds bound to ThrRS unambiguously confirmed their substrate-mimicking triple-site binding mode. Compound exhibited the best enzyme activity against ThrRS with IC = 19 nM and = 35.4 nM. Compounds , , and exhibited antibacterial activities with minimum inhibitory concentration values of 2-8 μg/mL against the tested bacteria, which are superior to those of the reported dual-site ThrRS inhibitors. Our study provides the first proof-of-concept for developing triple-site inhibitors against aaRSs, inspiring future aaRS-based drug discoveries.
PubMed: 35363470
DOI: 10.1021/acs.jmedchem.2c00134
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

227933

PDB entries from 2024-11-27

PDB statisticsPDBj update infoContact PDBjnumon